PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24292029-8	2013	Maternal and neonatal serum 25(OH)D3 levels showed a positive correlation with serum Ca++ and negative correlation with serum PO4 and ALP.	Calcifediol	28-36	alkaline phosphatase, placental	Homo sapiens	134-137	
22982627-7	2013	Second, 100nM 25(OH)D3 (p<0.01 vs. control, ANOVA) and 100nM PTH1-34 (p<0.05) significantly stimulated alkaline phosphatase (ALP) activity (a measure of osteoblastogenesis), with a synergistic effect when combined (p<0.001).	Calcifediol	14-22	alkaline phosphatase, placental	Homo sapiens	109-129	
22982627-7	2013	Second, 100nM 25(OH)D3 (p<0.01 vs. control, ANOVA) and 100nM PTH1-34 (p<0.05) significantly stimulated alkaline phosphatase (ALP) activity (a measure of osteoblastogenesis), with a synergistic effect when combined (p<0.001).	Calcifediol	14-22	alkaline phosphatase, placental	Homo sapiens	131-134	
23667735-8	2013	Maternal and neonatal serum 25(OH)D3 levels showed a positive correlation with serum Ca(++) and negative correlation with serum PO4 and ALP.	Calcifediol	28-36	alkaline phosphatase, placental	Homo sapiens	136-139	
20175051-7	2010	CONCLUSIONS: Treatment with oral calcitriol was associated with a decrease in the serum levels of ALP and 25(OH)D; treatment with oral calcidiol was associated with more physiological serum levels of 25(OH)D and with an increase in the serum levels of ALP and PTH: whether the statistically significant differences in the biochemical parameters achieved with the 2 treatments have a clinical relevance, remains a matter of debate.	Calcifediol	135-144	alkaline phosphatase, placental	Homo sapiens	252-255	
11350446-10	2001	Serum calcidiol level correlated inversely (P < 0.05) with serum iPTH and ALP, and parathyroid gland weight.	Calcifediol	6-15	alkaline phosphatase, placental	Homo sapiens	77-80